ArticleAdvanced genetics (Hoboken, N.J.)2021

A CRISPR/Cas9-based method for targeted DNA methylation enables cancer initiation in B lymphocytes.

Shota Katayama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.